Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 7Observational 1

Sponsor

Cancer Type

Endocrine 9Thoracic 2NET 1Dermatologic 1CNS 1

Conditions

Melanoma 467Skin Neoplasms 144Carcinoma, Basal Cell 94Breast Neoplasms 78Neoplasms 68Lymphoma, T-Cell, Cutaneous 62Lung Neoplasms 57Carcinoma, Squamous Cell 40Carcinoma, Non-Small-Cell Lung 40Mycosis Fungoides 39Uveal Melanoma 38Sezary Syndrome 37Lymphoma, Non-Hodgkin 35Lymphoma 35Keratosis, Actinic 35Pancreatic Neoplasms 34Sarcoma 33Prostatic Neoplasms 33Head and Neck Neoplasms 33Colorectal Neoplasms 33Leukemia, Lymphocytic, Chronic, B-Cell 31Ovarian Neoplasms 30Urinary Bladder Neoplasms 29Multiple Myeloma 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Lymphoma, B-Cell, Marginal Zone 28Colonic Neoplasms 28Lymphoma, Mantle-Cell 27Lymphoma, Follicular 27Leukemia 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Insulinoma × Dermatologic × Clear all
NCT03583528 2026-05-12

DOTATOC PET/CT for Imaging NET Patients

British Columbia Cancer Agency

Active not recruiting
800 enrolled
CNSDermatologicEndocrineNETThoracic

Carcinoid Tumor, Vipoma, Ganglioneuroma, Glucagonoma, Insulinoma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Pituitary Neoplasms, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Medullary, Neuroendocrine Tumors, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡